By Segun Adeyanju
A Nigerian-born researcher in the United States, Dr. Kayode Raheem, has made a groundbreaking advancement in the fight against cancer with the creation of an innovative artificial intelligence (AI), model.
Dr. Raheem, a PhD researcher in Bioinformatics and Systems Biology at the University of Nebraska Medical Center, developed SpatioMorph-Rx, a cutting-edge AI system designed to predict how cancer cells respond to treatments with high accuracy.
By integrating high-resolution imaging and genetic data, the model identifies regions within tumors that are resistant to therapy, helping doctors to personalize treatments, improve outcomes, and reduce side effects.
“SpatioMorph-Rx works like a digital microscope,” Dr. Raheem explained. “It zooms in on individual cells to analyze their response to specific drugs, mapping out clusters of resistant cells and guiding oncologists to better target therapy.”
The model was successfully tested using data from non-small cell lung cancer patients, where it accurately highlighted both resistant and responsive tumor areas.
Its advanced AI engine learns from patient data and applies its insights to new cases, while employing Explainable AI to ensure transparency and clinical trust.
Beyond this achievement, Dr. Raheem is also leading projects using AI to design personalized mRNA vaccines for breast cancer, triggering precise immune responses.
Additionally, he is exploring natural, plant-based drug discovery, particularly from Nigeria’s medicinal flora to create affordable, effective treatments.
Dr. Raheem’s work demonstrates the transformative power of AI in biomedical science and showcases the global impact of African researchers.
His innovations mark a new frontier in precision medicine and highlight the promise of homegrown talent on the world stage.
